European ophthalmologists debate

Article

European Ophthalmology, the social networking group for European ophthalmologists created and moderated by Ophthalmology Times Europe, has recently launched its new discussion forum.

European Ophthalmology, the social networking group for European ophthalmologists created and moderated by Ophthalmology Times Europe, has recently launched its new discussion forum.

We at Ophthalmology Times Europe want to know what you think on a variety of issues that impact directly on your community. A selection of the discussion comments posted will be published in a new feature in the magazine, starting next month. As the voice of the European ophthalmology community, we’d like to represent your views accurately, so your comments will be completely free from censorship: please feel free to discuss your opinions at will.

European Ophthalmology and Ophthalmology Times Europe have no material interest in these discussions: we merely wish to stimulate debate within the industry, and find out how you feel about issues affecting your industry, so that we can accurately represent and respond to your needs.

To become a member of our online community, please go to www.oteurope.com/forum. If you are already a member, please go to www.oteurope.com/discuss to start your own or join in with any of our current discussions.

In conjunction with the debates that we are running, we are also conducting a series of brief surveys (right), so even if your time is limited, you can still make your opinion count, simply at the touch of a button.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Related Content
© 2025 MJH Life Sciences

All rights reserved.